13 research outputs found
PROXIMITY TO COVID-19 ON MENTAL HEALTH SYMPTOMS AMONG HOSPITAL MEDICAL STAFF
Background: Exposure to patients with COVID-19 can have a significant impact on mental health of hospital medical staff. The
aim of this study was to examine the influence of proximity to patients with COVID-19 considering occupational position and gender
on the mental health of hospital staff.
Subjects and methods: N=78 participants were included in the study, with n=40 of them with direct contact to patients with
COVID-19 (51%); eight had contact with patients suspected of having COVID-19 (10%), and n=30 with no direct contact to people
with COVID-19 (39%).
Results: Multinomial regression analyses showed that proximity had a negative (inverse) influence on avoidance behaviour as
part of PTSD, physical symptoms, somatization, compulsiveness and anger expression-in as tendency to suppress anger. In addition,
there was a significant impact of the female gender on increased physical symptoms, while age, work experience and occupation had
no further influence.
Conclusions: These results that hospital medical staff is less psychologically stressed when closer to COVID-19 patients are
inconsistent with previous studies. Self-efficacy and locus of control in these situations are relevant for processing the trauma. In
summary, perception of personal risk is essential. Proximity is believed to be a proxy variable for personal risk perception. As a
synopsis of these results, regular briefings of the hospital staff are recommended to prevent psychological impairment. They should
contain specific information about conditions in the affected wards and the risk of infection, which could help reduce risk perception
of medical personnel
PROXIMITY TO COVID-19 ON MENTAL HEALTH SYMPTOMS AMONG HOSPITAL MEDICAL STAFF
Background: Exposure to patients with COVID-19 can have a significant impact on mental health of hospital medical staff. The
aim of this study was to examine the influence of proximity to patients with COVID-19 considering occupational position and gender
on the mental health of hospital staff.
Subjects and methods: N=78 participants were included in the study, with n=40 of them with direct contact to patients with
COVID-19 (51%); eight had contact with patients suspected of having COVID-19 (10%), and n=30 with no direct contact to people
with COVID-19 (39%).
Results: Multinomial regression analyses showed that proximity had a negative (inverse) influence on avoidance behaviour as
part of PTSD, physical symptoms, somatization, compulsiveness and anger expression-in as tendency to suppress anger. In addition,
there was a significant impact of the female gender on increased physical symptoms, while age, work experience and occupation had
no further influence.
Conclusions: These results that hospital medical staff is less psychologically stressed when closer to COVID-19 patients are
inconsistent with previous studies. Self-efficacy and locus of control in these situations are relevant for processing the trauma. In
summary, perception of personal risk is essential. Proximity is believed to be a proxy variable for personal risk perception. As a
synopsis of these results, regular briefings of the hospital staff are recommended to prevent psychological impairment. They should
contain specific information about conditions in the affected wards and the risk of infection, which could help reduce risk perception
of medical personnel
Identification of a BRCA2-Specific modifier locus at 6p24 related to breast cancer risk
Common genetic variants contribute to the observed variation in breast cancer risk for BRCA2 mutation carriers; those known to date have all been found through population-based genome-wide association studies (GWAS). To comprehensively identify breast cancer risk modifying loci for BRCA2 mutation carriers, we conducted a deep replication of an ongoing GWAS discovery study. Using the ranked P-values of the breast cancer associations with the imputed genotype of 1.4 M SNPs, 19,029 SNPs were selected and designed for inclusion on a custom Illumina array that included a total of 211,155 SNPs as part of a multi-consortial project. DNA samples from 3,881 breast cancer affected and 4,330 unaffected BRCA2 mutation carriers from 47 studies belonging to the Consortium of Investigators of Modifiers of BRCA1/2 were genotyped and available for analysis. We replicated previously reported breast cancer susceptibility alleles in these BRCA2 mutation carriers and for several regions (including FGFR2, MAP3K1, CDKN2A/B, and PTHLH) identified SNPs that have stronger evidence of association than those previously published. We also identified a novel susceptibility allele at 6p24 that was inversely associated with risk in BRCA2 mutation carriers (rs9348512; per allele HR = 0.85, 95% CI 0.80-0.90, P = 3.9×10−8). This SNP was not associated with breast cancer risk either in the general population or in BRCA1 mutation carriers. The locus lies within a region containing TFAP2A, which encodes a transcriptional activation protein that interacts with several tumor suppressor genes. This report identifies the first breast cancer risk locus specific to a BRCA2 mutation background. This comprehensive update of novel and previously reported breast cancer susceptibility loci contributes to the establishment of a panel of SNPs that modify breast cancer risk in BRCA2 mutation carriers. This panel may have clinical utility for women with BRCA2 mutations weighing options for medical prevention of breast cancer
Developing social life cycle assessment based on corporate social responsibility: A chemical process industry case regarding human rights
MSocial Life Cycle Assessment (S-LCA) uses a life cycle perspective to assess social impacts of products, and the S-LCA guidelines describe developing the system boundaries based on a factory-level perspective. However, such a perspective may exclude stakeholders with a negative social performance which are cooperating with a factory but are not directly involved with the product under study, and it can result in a step back on corporate social responsibility (CSR). Our study aimed to align S-LCA with the CSR concept. Therefore, we designed a case study for the manufacturing sector in which we practiced expanding the system boundaries of S-LCA. Our results showed larger social risks after expanding the system boundaries due to subsidiary and supplier companies located in countries with less strict regulations than the Netherlands, which is where the main organizations and parent company existed. We conclude that system boundaries expansion can result in more complete picture of the involved organizations, and lead practitioners to approach S-LCA with the goal of improving social conditions and identify companies which deserve excellent or poor social scores. Its usefulness is mostly expected when S-LCA practitioners aim to identify social hotspots in supply chains in socially sensitive markets.</p
Developing social life cycle assessment based on corporate social responsibility: A chemical process industry case regarding human rights
MSocial Life Cycle Assessment (S-LCA) uses a life cycle perspective to assess social impacts of products, and the S-LCA guidelines describe developing the system boundaries based on a factory-level perspective. However, such a perspective may exclude stakeholders with a negative social performance which are cooperating with a factory but are not directly involved with the product under study, and it can result in a step back on corporate social responsibility (CSR). Our study aimed to align S-LCA with the CSR concept. Therefore, we designed a case study for the manufacturing sector in which we practiced expanding the system boundaries of S-LCA. Our results showed larger social risks after expanding the system boundaries due to subsidiary and supplier companies located in countries with less strict regulations than the Netherlands, which is where the main organizations and parent company existed. We conclude that system boundaries expansion can result in more complete picture of the involved organizations, and lead practitioners to approach S-LCA with the goal of improving social conditions and identify companies which deserve excellent or poor social scores. Its usefulness is mostly expected when S-LCA practitioners aim to identify social hotspots in supply chains in socially sensitive markets.Energy & IndustryHeritage & ValuesEthics & Philosophy of Technolog
Impact of previous left atrial ablation procedures on the mechanism of left atrial flutter: A single‐centre experience
Complete genome sequences of porcine reproductive and respiratory syndrome viruses: perspectives on their temporal and spatial dynamics
Association of inflammation and disability accrual in patients with progressive-onset multiple sclerosis
Diagnosis and classification of optic neuritis
There is no consensus regarding the classification of optic neuritis, and precise diagnostic criteria are not available. This reality means that the diagnosis of disorders that have optic neuritis as the first manifestation can be challenging. Accurate diagnosis of optic neuritis at presentation can facilitate the timely treatment of individuals with multiple sclerosis, neuromyelitis optica spectrum disorder, or myelin oligodendrocyte glycoprotein antibody-associated disease. Epidemiological data show that, cumulatively, optic neuritis is most frequently caused by many conditions other than multiple sclerosis. Worldwide, the cause and management of optic neuritis varies with geographical location, treatment availability, and ethnic background. We have developed diagnostic criteria for optic neuritis and a classification of optic neuritis subgroups. Our diagnostic criteria are based on clinical features that permit a diagnosis of possible optic neuritis; further paraclinical tests, utilising brain, orbital, and retinal imaging, together with antibody and other protein biomarker data, can lead to a diagnosis of definite optic neuritis. Paraclinical tests can also be applied retrospectively on stored samples and historical brain or retinal scans, which will be useful for future validation studies. Our criteria have the potential to reduce the risk of misdiagnosis, provide information on optic neuritis disease course that can guide future treatment trial design, and enable physicians to judge the likelihood of a need for long-term pharmacological management, which might differ according to optic neuritis subgroups